Dec. 7th, 2009

furrbear: (Default)
Fans of the web comic Blur the Lines may now follow the posts on their LJ Friends List. I added the the RSS feed to LJ's syndication.

Add [livejournal.com profile] blurthelines_fd to your friends list. New comics appear Tuesdays, Thursdays, and Saturdays.
furrbear: (St.Dogbert)
furrbear: (Default)
Promising research. From insciences.org:
UCLA researchers demonstrate that stem cells can be engineered to kill HIV

Innovative strategy could be effective against other chronic viral diseases.

Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells — a process that potentially could be used against a range of chronic viral diseases.

The study, published Dec. 7 in the-peer reviewed online journal PLoS ONE, provides proof-of-principle — that is, a demonstration of feasibility — that human stem cells can be engineered into the equivalent of a genetic vaccine.

"We have demonstrated in this proof-of-principle study that this type of approach can be used to engineer the human immune system, particularly the T-cell response, to specifically target HIV-infected cells," said lead investigator Scott G. Kitchen, assistant professor of medicine in the division of hematology and oncology at the David Geffen School of Medicine at UCLA and a member of the UCLA AIDS Institute. "These studies lay the foundation for further therapeutic development that involves restoring damaged or defective immune responses toward a variety of viruses that cause chronic disease, or even different types of tumors."

Full InScience.org article

Journal article: Engineering Antigen-Specific T Cells from Genetically Modified Human Hematopoietic Stem Cells in Immunodeficient Mice.

Profile

furrbear: (Default)
furrbear

May 2013

S M T W T F S
   12 34
567891011
12131415161718
19202122232425
262728293031 

Most Popular Tags

Style Credit

Expand Cut Tags

No cut tags
Page generated Mar. 16th, 2026 01:37 am
Powered by Dreamwidth Studios